The SCN3A gene helps brain cells send electrical signals by making part of a sodium channel, a tiny gate that controls the flow of charged particles. This gene plays an important role in early brain development, so harmful variants can cause brain cells to become too excitable or develop differently. Some people with SCN3A variants have seizures, developmental delay, speech or movement differences, or changes in how the brain forms. Effects can vary widely, from milder epilepsy to more complex neurodevelopmental conditions.
What is a gene?
Genes are sections of DNA that give your cells instructions to make molecules or direct processes in the body. Some genes carry the information needed to produce proteins, which are the working parts of cells. Other genes mainly regulate when certain processes happen, where they happen, and how strongly they take place. Taken together, genes affect how the body develops and functions, and they can also shape how you respond to food, stress, or medications. If you want to look into this subject more closely, you can find more in the LearnHub.
Overview
SCN3AGene function
What if the gene works
The SCN3A gene helps make a sodium channel used by brain nerve cells. This channel supports electrical signaling and plays an important role in early brain development.
Risk
What if the gene does not work
Variants in the SCN3A gene are linked to a range of brain conditions, most often epilepsy or developmental and epileptic encephalopathy, sometimes with differences in brain formation. Milder and more severe variants can affect onset and severity.
Treatment
What does that mean for your treatment
No treatment or drug choice approach specific to the SCN3A gene is currently established. Early research is exploring whether some SCN3A variants may affect response to sodium channel blocking anti-seizure medicines, but this has not yet become a standard guide for care.
Conditions associated with SCN3A
Gene function
What if the gene works
In everyday life, the SCN3A gene helps brain cells send rapid electrical messages. It provides instructions for part of a sodium channel, a tiny doorway that opens for a moment and lets charged sodium particles enter the cell. This supports normal signaling across brain circuits.
The SCN3A gene provides instructions for one main piece of a voltage-gated sodium channel, a protein doorway in the nerve cell membrane. This doorway is built to respond to changes in the cell's electrical state.
When a brain cell is ready to fire, this channel opens very briefly and lets sodium move into the cell. That quick inward flow is one of the first steps in making an electrical signal.
The brief sodium current helps start and carry messages along nerve cells, which is a central part of what the SCN3A gene does in the brain. This supports everyday functions such as sensing, moving, and processing information.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help shape normal human variation, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic diversity. In some cases, though, a variant can change how a gene works more substantially and may contribute to or directly cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the SCN3A gene can alter how sodium channels open, close, or reach the cell surface, which is how SCN3A gene variants affect sodium channel function in nerve cells. Some variants make the channel too active, while others reduce activity or destabilize the protein; milder changes may shift channel behavior slightly, while more severe variants can greatly disrupt ion flow. Larger functional changes are often linked to earlier or more marked neurologic features.
How variants are linked to conditions
Pathogenic variants in the SCN3A gene can cause an SCN3A-related neurodevelopmental condition, often with seizures that start in infancy or childhood. In studies of SCN3A gene variants and epilepsy, the main linked features are developmental delay, intellectual disability, and sometimes differences in brain structure such as polymicrogyria. The picture varies widely, from milder epilepsy to more complex developmental needs.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widespread in the general population. Most do not have a direct effect on health and simply reflect natural human variation. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SCN3A-related conditions, risk is usually driven mainly by the gene change itself rather than by lifestyle or common environmental factors. There is not enough evidence to say that diet, exercise, or other daily habits lower the chance of developing the condition, though avoiding seizure triggers and getting regular medical follow-up can help reduce complications.
Inheritance of SCN3A variants
SCN3A-related conditions are usually inherited in an autosomal dominant pattern. This means a person needs one altered copy of the SCN3A gene to have the condition, and an affected parent can pass it to each child with a 50% chance. Inheritance of SCN3A gene variants is not always from a parent, because some people have a new (de novo) variant that was not inherited from either parent. When a parent carries the variant, it can be passed to sons or daughters equally.
What does my SCN3A result mean for my family?
For SCN3A, a disease-causing result is usually linked to a dominant pattern, so close relatives such as parents, brothers, sisters, and children may also carry the same change. In many families, this kind of SCN3A change happens for the first time in the affected person, so a parent does not always have it. The exact meaning for relatives depends on whether the result is clearly disease-causing and on the health condition involved.
Genetic information
Genetic testing
How you find out about variants
Testing for variants in the SCN3A gene usually uses a blood or saliva sample. In genetic testing for SCN3A variants, a lab reads the gene’s DNA code to look for changes that may help explain seizures, differences in brain development, or confirm whether a specific familial variant is present.
When should I consider getting a genetic test?
Genetic testing for the SCN3A gene may be worth considering in a child with unexplained seizures, especially when they start very early in life, or with seizures plus developmental delays or brain differences seen on scans. It can also help when similar symptoms run in the family.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but what it can tell you depends on the condition and the kind of variant involved. Factors such as lifestyle, environment, age, and medical history also shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or how strongly the drug acts on its target. This is common and helps explain why the same medication works well for one person, seems less helpful for another, or causes more side effects in someone else. Genetics is one part of the picture, along with age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support more informed and more individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the SCN3A gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice, so questions about medicines or side effects are best discussed with your doctor. In SCN3A-related epilepsy, early research suggests some gene changes may affect response to certain anti-seizure medicines, but this is not established enough for routine treatment decisions.